143 related articles for article (PubMed ID: 35537246)
1. MRI for evaluation of preoperative chemotherapy in osteosarcoma.
Yildirim O; Al Khatalin M; Kargin OA; Camurdan VB
Radiography (Lond); 2022 Aug; 28(3):593-604. PubMed ID: 35537246
[TBL] [Abstract][Full Text] [Related]
2. Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome.
Laux CJ; Berzaczy G; Weber M; Lang S; Dominkus M; Windhager R; Nöbauer-Huhmann IM; Funovics PT
Int Orthop; 2015 Jan; 39(1):97-104. PubMed ID: 25432323
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
[TBL] [Abstract][Full Text] [Related]
4. Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma?
Kanthawang T; Wudhikulprapan W; Phinyo P; Settakorn J; Pruksakorn D; Link TM; Pattamapaspong N
Br J Radiol; 2024 Feb; 97(1154):451-461. PubMed ID: 38308035
[TBL] [Abstract][Full Text] [Related]
5. T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.
White LM; Atinga A; Naraghi AM; Lajkosz K; Wunder JS; Ferguson P; Tsoi K; Griffin A; Haider M
Skeletal Radiol; 2023 Mar; 52(3):553-564. PubMed ID: 35778618
[TBL] [Abstract][Full Text] [Related]
6. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.
Brisse H; Ollivier L; Edeline V; Pacquement H; Michon J; Glorion C; Neuenschwander S
Pediatr Radiol; 2004 Aug; 34(8):595-605. PubMed ID: 15103428
[TBL] [Abstract][Full Text] [Related]
7. Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.
Byun BH; Kong CB; Lim I; Kim BI; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1553-62. PubMed ID: 24652233
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
[TBL] [Abstract][Full Text] [Related]
10. Pre-Operative chemotherapy response assessed by contrast-enhanced MRI can predict the prognosis of Enneking surgical margins in patients with osteosarcoma.
He F; Qin L; Bao Q; Zang S; He Q; Qiu S; Shen Y; Zhang W
J Orthop Res; 2019 Jan; 37(1):258-264. PubMed ID: 30255519
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
[TBL] [Abstract][Full Text] [Related]
12. Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Frezza AM; Beale T; Bomanji J; Jay A; Kalavrezos N; Dileo P; Whelan J; Strauss SJ
BMC Cancer; 2014 Jan; 14():23. PubMed ID: 24422949
[TBL] [Abstract][Full Text] [Related]
13. Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.
Prabowo Y; Setiawan I; Kamal AF; Kodrat E; Labib Zufar ML
Int J Surg Oncol; 2021; 2021():8843325. PubMed ID: 33996154
[TBL] [Abstract][Full Text] [Related]
14. Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.
Teo KY; Daescu O; Cederberg K; Sengupta A; Leavey PJ
PLoS One; 2022; 17(2):e0259564. PubMed ID: 35157711
[TBL] [Abstract][Full Text] [Related]
15. Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
Lindner NJ; Scarborough MT; Spanier SS; Enneking WF
J Cancer Res Clin Oncol; 1998; 124(10):575-80. PubMed ID: 9829862
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
Habre C; Dabadie A; Loundou AD; Banos JB; Desvignes C; Pico H; Aschero A; Colavolpe N; Seiler C; Bouvier C; Peltier E; Gentet JC; Baunin C; Auquier P; Petit P
Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
[TBL] [Abstract][Full Text] [Related]
17. Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.
Bajpai J; Gamnagatti S; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Safaya R; Bakhshi S
Pediatr Radiol; 2011 Apr; 41(4):441-50. PubMed ID: 20978754
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.
Im HJ; Kim TS; Park SY; Min HS; Kim JH; Kang HG; Park SE; Kwon MM; Yoon JH; Park HJ; Kim SK; Park BK
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):39-49. PubMed ID: 21953008
[TBL] [Abstract][Full Text] [Related]
19. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
[TBL] [Abstract][Full Text] [Related]
20. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
